WallStSmart

Lazard Ltd (LAZ)vsMorgan Stanley (MS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Morgan Stanley generates 2333% more annual revenue ($77.83B vs $3.20B). MS leads profitability with a 25.9% profit margin vs 7.1%. LAZ appears more attractively valued with a PEG of 1.00. MS earns a higher WallStSmart Score of 75/100 (B).

LAZ

Buy

53

out of 100

Grade: C-

Growth: 3.3Profit: 6.0Value: 6.3Quality: 5.5
Piotroski: 3/9Altman Z: 2.05

MS

Strong Buy

75

out of 100

Grade: B

Growth: 9.3Profit: 8.0Value: 5.7Quality: 3.5
Piotroski: 5/9Altman Z: 0.38

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LAZ2 strengths · Avg: 9.0/10
Return on EquityProfitability
31.5%10/10

Every $100 of equity generates 31 in profit

PEG RatioValuation
1.008/10

Growing faster than its price suggests

MS6 strengths · Avg: 9.2/10
Market CapQuality
$336.70B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
41.6%10/10

Strong operational efficiency at 41.6%

EPS GrowthGrowth
62.4%10/10

Earnings expanding 62.4% YoY

Profit MarginProfitability
25.9%9/10

Keeps 26 of every $100 in revenue as profit

P/E RatioValuation
17.3x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
28.0%8/10

Revenue surging 28.0% year-over-year

Areas to Watch

LAZ4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

Profit MarginProfitability
7.1%3/10

7.1% margin — thin

Operating MarginProfitability
4.8%3/10

Operating margin of 4.8%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

MS4 concerns · Avg: 2.3/10
PEG RatioValuation
1.874/10

Expensive relative to growth rate

Free Cash FlowQuality
$-3.57B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.382/10

Distress zone — elevated risk

Debt/EquityHealth
4.751/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : LAZ

The strongest argument for LAZ centers on Return on Equity, PEG Ratio. PEG of 1.00 suggests the stock is reasonably priced for its growth.

Bull Case : MS

The strongest argument for MS centers on Market Cap, Operating Margin, EPS Growth. Profitability is solid with margins at 25.9% and operating margin at 41.6%. Revenue growth of 28.0% demonstrates continued momentum.

Bear Case : LAZ

The primary concerns for LAZ are Revenue Growth, Profit Margin, Operating Margin. Debt-to-equity of 2.35 is elevated, increasing financial risk.

Bear Case : MS

The primary concerns for MS are PEG Ratio, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.75 is elevated, increasing financial risk.

Key Dynamics to Monitor

LAZ profiles as a value stock while MS is a growth play — different risk/reward profiles.

LAZ carries more volatility with a beta of 1.42 — expect wider price swings.

MS is growing revenue faster at 28.0% — sustainability is the question.

LAZ generates stronger free cash flow (201M), providing more financial flexibility.

Bottom Line

MS scores higher overall (75/100 vs 53/100), backed by strong 25.9% margins and 28.0% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lazard Ltd

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Lazard Ltd, is a financial advisory and asset management firm in North America, Europe, Asia, Australia, and Central and South America. The company is headquartered in Hamilton, Bermuda.

Morgan Stanley

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Morgan Stanley is an American multinational investment bank and financial services company headquartered at 1585 Broadway in the Morgan Stanley Building, Midtown Manhattan, New York City.

Want to dig deeper into these stocks?